ROSSARI BIOTECH LIMITED

Manufactures specialty chemicals across three core segments — Home Care, Personal Care & Pharma Chemicals (HPPC), Textile Specialty Chemicals (TSC) and Animal Health & Nutrition (AHN) — serving B2B customers in home care, personal care, pharma, textiles, agrochemicals, performance chemicals and animal nutrition. Runs two manufacturing plants at Silvassa and Dahej, with subsidiary Unitop Chemicals providing ethoxylation capacity, and has commissioned a new 5,000 MTPA blending facility in Thailand for Southeast Asian markets. A greenfield project in Saudi Arabia is in progress, with management indicating about 1.5 years from announcement to first kilo of production. Customers in 50+ countries are served, with a dedicated R&D centre in Navi Mumbai supporting an innovation pipeline of biosurfactants, NMMO, MDEA, spray-cooled powders and pharma formulations. The B2C consumer business is being exited while institutional cleaning is retained, with a steady-state 15% EBITDA margin targeted over 2-3 years via product-mix upgrade. Raw materials — primarily ethylene oxide and phenol — are the largest cost at 66.9% of revenue, while the Andheri office was sold and net debt reduced to Rs. 248 crore in Q1 FY27.